Alps Advisors Inc G1 Therapeutics, Inc. Transaction History

Alps Advisors Inc

$14.8 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 09, 2022	SELL	$10.16 - $16.17 $527,293 - $839,206	-51,899 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$13.16 - $22.47 $46,296 - $79,049	-3,518 Reduced 6.35%	51,899 $696,000
Q2 2021 Aug 11, 2021	BUY	$19.57 - $26.32 $1.08 Million - $1.46 Million	55,417 New	55,417 $1.22 Million
Q4 2020 Feb 03, 2021	SELL	$10.99 - $20.4 $532,773 - $988,951	-48,478 Closed	0 $0
Q3 2020 Nov 04, 2020	SELL	$11.55 - $23.75 $34,673 - $71,297	-3,002 Reduced 5.83%	48,478 $560,000
Q2 2020 Aug 05, 2020	SELL	$9.57 - $24.37 $161,197 - $410,488	-16,844 Reduced 24.65%	51,480 $1.25 Million
Q1 2020 May 06, 2020	SELL	$9.07 - $26.32 $66,827 - $193,925	-7,368 Reduced 9.73%	68,324 $753,000
Q4 2019 Feb 07, 2020	BUY	$20.54 - $31.0 $17,253 - $26,040	840 Added 1.12%	75,692 $2 Million
Q3 2019 Nov 04, 2019	SELL	$22.78 - $40.58 $81,096 - $144,464	-3,560 Reduced 4.54%	74,852 $1.71 Million
Q2 2019 Aug 07, 2019	SELL	$16.03 - $31.1 $182,806 - $354,664	-11,404 Reduced 12.7%	78,412 $2.4 Million
Q1 2019 May 01, 2019	BUY	$14.4 - $21.45 $55,944 - $83,333	3,885 Added 4.52%	89,816 $1.49 Million
Q4 2018 Feb 04, 2019	BUY	$16.51 - $51.33 $442,748 - $1.38 Million	26,817 Added 45.36%	85,931 $1.65 Million
Q3 2018 Oct 25, 2018	BUY	$43.15 - $67.97 $502,956 - $792,258	11,656 Added 24.56%	59,114 $3.09 Million
Q2 2018 Aug 02, 2018	BUY	$35.06 - $51.17 $562,677 - $821,227	16,049 Added 51.1%	47,458 $2.06 Million
Q2 2018 Jul 25, 2018	SELL	$35.06 - $51.17 $236,374 - $344,988	-6,742 Reduced 17.67%	31,409 $623,000
Q1 2018 May 01, 2018	BUY	$19.05 - $41.76 $128,435 - $281,545	6,742 Added 21.47%	38,151 $1.41 Million
Q4 2017 Feb 05, 2018	BUY	$19.01 - $26.2 $69,253 - $95,446	3,643 Added 13.12%	31,409 $623,000
Q3 2017 Nov 03, 2017	BUY	$12.53 - $27.12 $347,907 - $753,013	27,766	27,766 $691,000

Others Institutions Holding GTHX

# of Institutions

Shares Held

3.55M

Call Options Held

11.7K

Put Options Held

View Full List

About G1 Therapeutics, Inc.

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

More about GTHX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.

Account